Forum Moderators: open
Despite great quarterly results overall, Inktomi's stock price leaves tremendous downside risk. The shares certainly look more600 P/E ratio!!! YEOW!
attractive after dropping 46% from their March peak. But (still) trading around 600 times 2001 earnings and nearly 85 times sales, the stock's valuation is frothy by any measure.
So, before the 46% drop the p/e ratio must have been close to a thousand...
Edited by: littleman